Jennison Associates

Jennison Associates’s Regulus Therapeutics RGLS Stock Holding History

Jennison Associates’s Portfolio RGLS Stock Details RGLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,395	Closed	-$4.46M	–	759
2015 Q2	$4.46M	Buy	3,395 +34	+1%	+$54.9K	﹤0.01%	546
2015 Q1	$6.83M	Buy	3,361 +10	+0.3%	+$21.7K	0.01%	507
2014 Q4	$6.45M	Buy	3,351 +658	+24%	+$1.17M	0.01%	500
2014 Q3	$2.21M	Buy	2,693 +4	+0.1%	+$3.38K	﹤0.01%	574
2014 Q2	$2.6M	Sell	2,689 -316	-11%	-$271K	﹤0.01%	552
2014 Q1	$3.25M	Buy	3,005 +10	+0.3%	+$11.1K	﹤0.01%	551
2013 Q4	$2.66M	Buy	2,995 +12	+0.4%	+$10.3K	﹤0.01%	549
2013 Q3	$3.38M	Buy	+2,983	New	+$3.52M	﹤0.01%	527

Other funds holding RGLS

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return